LUISA ARELLANO: Open Payments
NPI 1275081770 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 33 payments from 17 companies in 2025. Trend: 2023 $354 · 2024 $0 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $232 |
| Madrigal Pharmaceuticals | 3 | $163 |
| Phathom Pharmaceuticals, Inc. | 4 | $143 |
| Novo Nordisk Inc | 2 | $125 |
| Ardelyx, Inc. | 2 | $114 |
| Janssen Biotech, Inc. | 4 | $106 |
| Janssen Scientific Affairs, LLC | 3 | $69 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| UCB, Inc. | 1 | $41 |
| GENZYME CORPORATION | 1 | $34 |
Products named: TREMFYA, REZDIFFRA, VOQUEZNA, LINZESS, Wegovy, IBSRELA, SKYRIZI, VOWST.
Industry payments across TX — which companies pay providers there.
